Clinical Trials
8 trialsNCT07582432 2026-05-12
SIGMA
Grifols Biologicals, LLC
Phase 3 Recruiting
NCT06976476 2026-03-11
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT04728425 2025-04-27
MG_SCIG
University Health Network, Toronto
Phase 2 Completed
NCT02774239 2023-02-21
SCIG-MG
University of Alberta
Phase 3 Completed
NCT02100969 2021-06-02
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
University of Kansas Medical Center
Phase 2 Completed
NCT03211065 2021-04-19
Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig
Rochester General Hospital
Phase 2/3 Completed
NCT03730129 2020-08-26
Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig
Rochester General Hospital
Phase 2/3 Completed
NCT01828294 2019-04-03
SIMM
St. Louis University
Phase 1 Terminated